Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;138(3):235-243.
doi: 10.1590/1516-3180.2019.0541.R1.19022020. Epub 2020 Jun 22.

Free access to medicines among older adults in primary care: a cross-sectional study

Isabela Vaz Leite Pinto  1 , Marina Guimarães Lima  2 , Laís Lessa Neiva Pantuzza  2 , Maria das Graças Braga Ceccato  2 , Micheline Rosa Silveira  2 , Adriano Max Moreira Reis  2
Affiliations

Free access to medicines among older adults in primary care: a cross-sectional study

Isabela Vaz Leite Pinto et al. Sao Paulo Med J. 2020 Jun.

Abstract

Background: Access to medicines is an important indicator of healthcare system quality and capacity to resolve problems. The healthcare system needs to ensure free access to medicines for elderly people, in order to provide greater effectiveness of disease control, thus reducing morbidity and mortality, and improving health and quality of life.

Objectives: To analyze the frequency of free access to medication among older adults within primary care and determine the factors associated with free access.

Design and setting: Cross-sectional study at two primary care units.

Methods: Free access was defined as provision of all medicines through pharmacies within the Brazilian National Health System and through the Brazilian program for free medicines in private pharmacies. We investigated the sociodemographic, clinical, functional and pharmacotherapeutic characteristics of older adults. Multivariate logistic regression was performed to identify factors associated with free access to medicines.

Results: This study included 227 older adults, among whom 91 (40.1%) had free full access to prescription drugs. A direct association with age ≤ 70 years and indirect associations with polypharmacy and multimorbidity (P < 0.05) were found.

Conclusions: Age ≤ 70 years increases the likelihood of having free full access to medicines, and older adults with multimorbidity and polypharmacy use have a lower likelihood of access. Identification of factors associated with free access to medicines among elderly people provides elements to guide the Brazilian National Health System in implementing access improvement actions.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests: The authors declare that there was no conflict of interest

Figures

Figure 1.
Figure 1.. Characterization of access to medicines among the 227 older adults.
See this image and copyright information in PMC

References

    1. Godman B, Malmström RE, Diogene E, et al. Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? Expert Rev Clin Pharmacol. 2015;8(1):77–94. doi: 10.1586/17512433.2015.990380. - DOI - PubMed
    1. Ramos LR, Tavares NU, Bertoldi AD, et al. Polypharmacy and Polymorbidity in Older Adults in Brazil: a public health challenge. Rev Saude Publica. 2016;50(2):9s–9s. doi: 10.1590/S1518-8787.2016050006145. - DOI - PMC - PubMed
    1. Oliveira MA, Luiza VL, Tavares NU, et al. Access to medicines for chronic diseases in Brazil: a multidimensional approach. Rev Saude Publica. 2016;50(2):6s–6s. doi: 10.1590/S1518-8787.2016050006161. - DOI - PMC - PubMed
    1. Tavares NU, Luiza VL, Oliveira MA, et al. Free access to medicines for the treatment of chronic diseases in Brazil. Rev Saude Publica. 2016;50(2):7s–7s. doi: 10.1590/S1518-8787.2016050006118. - DOI - PMC - PubMed
    1. Wirtz VJ, Moucheraud C. Beyond availability and affordability: how access to medicines affects non-communicable disease outcomes. Lancet Public Health. 2017;2(9):e390–e391. doi: 10.1016/S2468-2667(17)30168-8. - DOI - PubMed